• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effect of a community-wide asthma intervention on appropriate use of inhaled corticosteroids.社区范围哮喘干预对吸入性皮质类固醇合理使用的影响。
J Urban Health. 2011 Feb;88 Suppl 1(Suppl 1):144-55. doi: 10.1007/s11524-010-9476-y.
2
Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.美国哮喘患者中既往医疗保健使用与吸入皮质类固醇和长效β2-肾上腺素能激动剂联合治疗起始的相关性。
Clin Ther. 2009 Nov;31(11):2574-83. doi: 10.1016/j.clinthera.2009.11.007.
3
Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.美国商业保险人群中哮喘患者吸入性糖皮质激素与长效β2肾上腺素能激动剂联合疗法的合理使用情况
Curr Med Res Opin. 2009 Sep;25(9):2251-8. doi: 10.1185/03007990903155915.
4
Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.吸入长效β2受体激动剂与吸入性糖皮质激素联合使用与高剂量吸入性糖皮质激素治疗儿童和成人持续性哮喘的比较
Cochrane Database Syst Rev. 2005 Oct 19(4):CD005533. doi: 10.1002/14651858.CD005533.
5
Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.双重麻烦:哮喘药物使用不当对医疗资源利用的影响
CMAJ. 2001 Mar 6;164(5):625-31.
6
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.在未使用过类固醇的成年持续性哮喘患者中,吸入长效β2受体激动剂联合吸入性类固醇作为一线治疗方案。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD005307. doi: 10.1002/14651858.CD005307.
7
Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.不同吸入性糖皮质激素及其与长效β2受体激动剂联合使用治疗12岁以下儿童慢性哮喘的比较效果的系统评价和经济学分析
Health Technol Assess. 2008 May;12(20):1-174, iii-iv. doi: 10.3310/hta12200.
8
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.吸入性糖皮质激素与β-肾上腺素能激动剂联合治疗气道疾病:现状与未来
Eur J Clin Pharmacol. 2009 Sep;65(9):853-71. doi: 10.1007/s00228-009-0682-z. Epub 2009 Jun 26.
9
Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.哮喘孕妇使用长效β₂-激动剂和吸入皮质类固醇联合治疗与高剂量吸入皮质类固醇单一疗法相比的先天畸形风险。
J Allergy Clin Immunol. 2015 Jan;135(1):123-30. doi: 10.1016/j.jaci.2014.07.051. Epub 2014 Sep 13.
10
Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.不同吸入性糖皮质激素及其与长效β2受体激动剂联合使用治疗12岁及以上成人和儿童慢性哮喘比较效果的系统评价与经济学分析
Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. doi: 10.3310/hta12190.

引用本文的文献

1
The impact of peer support and mp3 messaging on adherence to inhaled corticosteroids in minority adolescents with asthma: a randomized, controlled trial.同伴支持和 mp3 短信对少数族裔青少年哮喘患者吸入皮质类固醇依从性的影响:一项随机对照试验。
J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):485-93. doi: 10.1016/j.jaip.2013.06.010. Epub 2013 Aug 30.
2
Controlling Asthma in American Cities: major themes, persistent challenges, and next steps.美国城市中的哮喘控制:主要主题、持续挑战及后续步骤
J Urban Health. 2011 Feb;88 Suppl 1(Suppl 1):30-7. doi: 10.1007/s11524-010-9474-0.
3
Conceptual framework of the Controlling Asthma in American Cities Project.美国城市哮喘控制项目的概念框架。
J Urban Health. 2011 Feb;88 Suppl 1(Suppl 1):7-15. doi: 10.1007/s11524-010-9473-1.
4
Considerations and challenges for planning a public health approach to asthma.规划以公共卫生方法应对哮喘的考虑因素和挑战。
J Urban Health. 2011 Feb;88 Suppl 1(Suppl 1):16-29. doi: 10.1007/s11524-010-9515-8.

本文引用的文献

1
Are we closing the disparities gap? Small-area analysis of asthma in Chicago.我们正在缩小差距吗?芝加哥哮喘的小区域分析。
Chest. 2007 Nov;132(5 Suppl):858S-865S. doi: 10.1378/chest.07-1913.
2
Inner-city asthma: the role of the community.城市中心区哮喘:社区的作用。
Chest. 2007 Nov;132(5 Suppl):831S-839S. doi: 10.1378/chest.07-1911.
3
Identification of asthmatic children using prescription data and diagnosis.利用处方数据和诊断结果识别哮喘儿童。
Eur J Clin Pharmacol. 2007 Jun;63(6):605-11. doi: 10.1007/s00228-007-0286-4. Epub 2007 Mar 27.
4
Does your child have asthma? Filled prescriptions and household report of child asthma.您的孩子患有哮喘吗?儿童哮喘的处方填写情况及家庭报告。
J Pediatr Health Care. 2006 Nov-Dec;20(6):374-83. doi: 10.1016/j.pedhc.2006.02.003.
5
Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions.哮喘和慢性阻塞性肺疾病患者的续方依从性:药房记录数据库与人工收集的重复处方的比较
Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):441-8. doi: 10.1002/pds.1321.
6
The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes.控制器药物与哮喘总用药量的比例与以患者为中心的结果以及使用结果相关。
Chest. 2006 Jul;130(1):43-50. doi: 10.1378/chest.130.1.43.
7
Short-acting beta-agonist prescription fills as a marker for asthma morbidity.
Chest. 2005 Aug;128(2):602-8. doi: 10.1378/chest.128.2.602.
8
Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data.从处方数据中识别被诊断为哮喘的全科医疗患者及其病情加重发作情况。
Eur J Clin Pharmacol. 2002 Jan;57(11):819-25. doi: 10.1007/s00228-001-0395-4.
9
An evaluation of Open Airways for Schools: using college students as instructors.对“学校开放气道法”的评估:以大学生作为指导人员
J Asthma. 2001 Jun;38(4):337-42. doi: 10.1081/jas-100000261.
10
Using the Open Airways curriculum to improve self-care for third grade children with asthma.使用开放气道课程来改善三年级哮喘儿童的自我护理。
J Sch Health. 1998 Oct;68(8):329-33. doi: 10.1111/j.1746-1561.1998.tb00595.x.

社区范围哮喘干预对吸入性皮质类固醇合理使用的影响。

Effect of a community-wide asthma intervention on appropriate use of inhaled corticosteroids.

机构信息

Section of Pulmonary and Critical Care Medicine, The University of Chicago, Chicago, IL, USA.

出版信息

J Urban Health. 2011 Feb;88 Suppl 1(Suppl 1):144-55. doi: 10.1007/s11524-010-9476-y.

DOI:10.1007/s11524-010-9476-y
PMID:21337060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3042072/
Abstract

Individuals with asthma living in the inner city experience increased asthma morbidity and mortality compared to the US average. The Controlling Asthma in America's Cities Project's Chicago site used a multifaceted approach to improve asthma care. The diverse scope of this project's interventions necessitated the use of novel methods to assess the effect of these interventions on the entire study area. Asthma-related medication-dispensing data were obtained from a large pharmacy chain for prescriptions filled in calendar years 2004-2006 for all individuals aged 5-17 years living in Chicago who filled at least four asthma-related medications within a 12-month period. Inhaled corticosteroid (ICS) use was considered inadequate if an individual had four or more dispensings of a short-acting beta-agonist without at least four dispensings of an ICS agent. Logistic regression was used to compare adequate ICS use in individuals within the intervention area with ICS use in the remainder of the city, after controlling for gender, insurance status, race, and poverty. A significant difference in adequate ICS use was found in years 2 (2005) and 3 (2006) of the project for individuals aged 5-9 in the intervention area (odds ratios for adequate ICS use-year 2, 1.26; CI, 1.04-1.53, p = 0.04; year 3, 1.30; CI, 1.08-1.55, p = 0.008) compared to individuals aged 5-9 in the remainder of the city. There was no similar significant difference in the 10-17 age group. These findings suggest an effect of a large multifaceted asthma intervention in improving medication use in the targeted age group. This methodology might also prove useful in the future for assessing the effect of similar interventions.

摘要

与美国平均水平相比,居住在市中心的哮喘患者经历了更高的哮喘发病率和死亡率。“控制美国城市哮喘项目”的芝加哥站点采用了多方面的方法来改善哮喘护理。该项目干预措施的多样性需要使用新的方法来评估这些干预措施对整个研究区域的影响。从一家大型连锁药店获得了 2004-2006 年期间所有年龄在 5-17 岁之间的居住在芝加哥的个人的哮喘相关药物配药数据,这些人在 12 个月内至少配了四种哮喘相关药物。如果一个人在没有至少四种吸入皮质激素(ICS)药物的情况下,配了四种或更多种短效β-激动剂,那么就认为其 ICS 使用不足。使用逻辑回归比较了干预区和城市其余地区的个人在控制性别、保险状况、种族和贫困后使用适当的 ICS 的情况。在项目的第 2 年(2005 年)和第 3 年(2006 年),干预区年龄在 5-9 岁的个人中发现了适当的 ICS 使用差异(适当的 ICS 使用的优势比,第 2 年为 1.26;置信区间,1.04-1.53,p=0.04;第 3 年为 1.30;置信区间,1.08-1.55,p=0.008),与城市其余地区年龄在 5-9 岁的个人相比。在 10-17 岁年龄组中没有类似的显著差异。这些发现表明,大型多方面哮喘干预措施的效果改善了目标年龄组的药物使用。这种方法在未来评估类似干预措施的效果时也可能证明是有用的。